154 related articles for article (PubMed ID: 35323929)
1. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
[TBL] [Abstract][Full Text] [Related]
4. Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
Chevalier B; Coppin L; Romanet P; Cuny T; Maiza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38288531
[TBL] [Abstract][Full Text] [Related]
5. Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (
Lines KE; Nachtigall LB; Dichtel LE; Cranston T; Boon H; Zhang X; Kooblall KG; Stevenson M; Thakker RV
J Endocr Soc; 2020 Nov; 4(11):bvaa142. PubMed ID: 33150274
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing in prolactinomas: a cohort study.
Boukerrouni A; Cuny T; Anjou T; Raingeard I; Ferrière A; Grunenwald S; Maïza JC; Marquant E; Sahakian N; Fodil-Cherif S; Salle L; Niccoli P; Randrianaivo H; Sonnet E; Chevalier N; Thuillier P; Vezzosi D; Reynaud R; Dufour H; Brue T; Tabarin A; Delemer B; Kerlan V; Castinetti F; Barlier A; Romanet P
Eur J Endocrinol; 2023 Dec; 189(6):567-574. PubMed ID: 37956455
[TBL] [Abstract][Full Text] [Related]
7. Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review.
Gao Y; Li R; Wu L; Yang H; Mao J; Zhao W
Endocrine; 2023 Nov; 82(2):442-449. PubMed ID: 37668926
[TBL] [Abstract][Full Text] [Related]
8. A Japanese Family Meeting the Clinical Diagnostic Criteria for MEN1 with a MEN1 Variant of Uncertain Significance.
Matsubayashi H; Kiyozumi Y; Harada R; Mukaigawa T; Sugiura T; Ishiwatari H; Sato J; Niiya F; Nakashima K; Kado N; Nishimura S; Honda G; Ohike N
Intern Med; 2024 Apr; 63(8):1119-1123. PubMed ID: 37661450
[TBL] [Abstract][Full Text] [Related]
9. PDP type brain tumor in association with multiple endocrine neoplasia type 1.
Einarsson HB; Frederiksen AL; Pedersen IS; Ettrup MS; Wirenfeldt M; Boldt H; Nguyen N; Andersen MS; Bjarkam CR; Poulsen FR
Heliyon; 2024 Mar; 10(6):e27418. PubMed ID: 38510015
[TBL] [Abstract][Full Text] [Related]
10. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
Libánský P; Čarková J; Kushnir I; Matějková Běhanová M; Procyklová K; Šedý J; Vaculová M; Včelák J; Zikán V; Adámek S
Physiol Res; 2023 Dec; 72(S4):S423-S427. PubMed ID: 38116778
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract][Full Text] [Related]
13. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 Jan; ():. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
14. Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly.
Nachtigall LB; Guarda FJ; Lines KE; Ghajar A; Dichtel L; Mumbach G; Zhao W; Zhang X; Tritos NA; Swearingen B; Miller KK; Thakker RV
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2271-81. PubMed ID: 32311048
[TBL] [Abstract][Full Text] [Related]
15. A Novel Pathogenic
Horikoshi H; Arita J; Hasegawa K; Makita N
JCEM Case Rep; 2023 May; 1(3):luad078. PubMed ID: 37908584
[TBL] [Abstract][Full Text] [Related]
16. Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M; Mungo G; De Marco Zompit M; Segatto I; Belletti B; Baldassarre G
Front Endocrinol (Lausanne); 2018; 9():393. PubMed ID: 30065701
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
